Drug intelligence / Profile preview

iva annua pollen extract

Development stage
Unknown
Lead developer
Greer Laboratories
Administration
Subcutaneous, Intradermal, Percutaneous, Sublingual, Intranasal, Ophthalmic
01

Overview

Iva annua pollen extract is a non-standardized biological allergenic extract derived from the pollen of the *Iva annua* plant, commonly known as Annual Marsh-Elder or Rough Marsh Elder. It is primarily utilized in clinical practice for the diagnosis and treatment of Type I immediate hypersensitivity allergies. As a diagnostic tool, it is used in skin testing (percutaneous or intradermal) to identify patients sensitized to Marsh-Elder allergens by eliciting a localized IgE-mediated allergic response. As a therapeutic agent, it is used in allergen immunotherapy (hyposensitization), where gradually increasing doses are administered subcutaneously to induce immunological tolerance and reduce symptoms associated with allergic rhinitis or asthma. The product is manufactured by Greer Laboratories and is approved for use in the United States.

Brand names
True Rough Marsh Elder
Other names
Iva annua pollenAnnual Marsh-Elder pollenRough Marsh Elder pollenAnnual Marsh Elder

Beyond the preview

Go deeper on iva annua pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iva annua pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call